• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 98 of 100
Inside Rite Aid Ahead of Earnings Reports
Retail
Rite Aid takes aim at CVS with a $2 billion purchase
By Laura LorenzettiFebruary 11, 2015
Thiel, partner of Founders Fund, speaks during the panel discussion at the Milken Institute Global Conference in Beverly Hills, California
Leadership
Peter Thiel has never met a regulation he didn’t hate
By Ben GeierFebruary 10, 2015
161135392
Features
Biosimilars may one day save your life. But what are they?
By Laura LorenzettiFebruary 6, 2015
IL: Corporations In Illinois
Finance
Fat Pharma: Pfizer-Hospira and the top 10 overpriced drug deals ever
By Jen WiecznerFebruary 6, 2015
American Pharmaceutical Company Pfizer Propose To Takeover British AstraZeneca
Finance
Pfizer to acquire Hospira in a deal worth about $15 billion
By Fortune EditorsFebruary 5, 2015
Close-up of various intravenous solutions used during operations
Features
There’s a national shortage of saline solution. Yeah, we’re talking salt water. Huh?
By Erika FryFebruary 5, 2015
Earns Pfizer
Features
In speed mode, FDA approves Pfizer’s big new drug early
By Jen WiecznerFebruary 4, 2015
FDA rescinds ‘breakthrough’ status for Merck’s hepatitis C drug
Finance
FDA rescinds ‘breakthrough’ status for Merck’s hepatitis C drug
By Laura LorenzettiFebruary 4, 2015
Exclusive Look At Pharmaceuticals Manufacturing Inside Lupin Ltd. Facility, India's Third-Largest Drugmaker
Features
Is it time for the FDA to consider cost when it comes to new drugs?
By Laura LorenzettiFebruary 4, 2015
Inside of a Gilead Sciences Lab
Tech
Bigger drug discounts put question mark over Gilead’s stellar run
By Reuters and Fortune EditorsFebruary 4, 2015
Pharmacy technician Andrea Tibbetts counts out pills to fill an order for generic medications at Por
Finance
How to save on your prescription meds (yep, there’s an app for that)
By Jean ChatzkyFebruary 3, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
Finance
After Allergan loss, is Valeant dumpster diving?
By Jen WiecznerJanuary 31, 2015
Key Speakers At Osons La France Economic Summit
Leadership
Fire in haste, repent at leisure: Sanofi wonders why it can’t find a new CEO
By ReutersJanuary 30, 2015
American Pharmaceutical Company Pfizer Propose To Takeover British AstraZeneca
Features
Pfizer’s outlook disappoints as it struggles with patent expirations
By Laura LorenzettiJanuary 27, 2015
Regeneron vaults ahead of Amgen in race to market cholesterol drug
Features
Regeneron vaults ahead of Amgen in race to market cholesterol drug
By ReutersJanuary 26, 2015
1...
  • 96
  • 97
  • 98
  • 99
  • 100
100
Most Popular
Success
IBM’s CEO disagrees with JPMorgan CEO Jamie Dimon’s disdain for texting in meetings: ‘Telling people they can't use their technology would be weird’placeholder alt text
By Preston ForeAugust 29, 2026
Success
Richard Branson double-booked his own job interview. The candidate stuck in traffic with him for 2.5 hours is now Virgin's CEOplaceholder alt text
By Preston ForeAugust 29, 2026
Big Tech
Tech billionaires and executives like Evan Spiegel and Peter Thiel are publicly shielding their children from the products that made them richplaceholder alt text
By Marco Quiroz-GutierrezAugust 29, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.